Valuation BioSenic SA

Stocks

Real-time Euronext Bruxelles 12:55:00 2026-10-29 EDT			5-day change	1st Jan Change
0.002000 ^EUR	0.00%		0.00%	-13.04%

09-23	BioSenic S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
25-10-27	BioSenic S.A. Reports Earnings Results for the Half Year Ended June 30, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024
Market Cap ¹	2.998	9.987	1.879
Change	-	233.11%	-81.19%
Enterprise Value (EV) ¹	24.94	38.03	29.21
Change	-	52.47%	-23.17%
P/E	-5.65x	-0.29x	-0.28x
PBR	6.54x	-0.44x	-0.07x
PEG	-	-0x	0x
Capitalization / Revenue	10.1x	29.7x	18.4x
EV / Revenue	84.3x	113x	286x
EV / EBITDA	-10.8x	-5.43x	-5.94x
EV / EBIT	-10.8x	-5.4x	-5.61x
EV / FCF	-13.3x	-17x	-7.16x
FCF Yield	-7.49%	-5.89%	-14%
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-0.017	-0.2102	-0.0206
Distribution rate	-	-	-
Net sales ¹	0.296	0.336	0.102
EBITDA ¹	-2.299	-6.998	-4.915
EBIT ¹	-2.318	-7.039	-5.206
Net income ¹	-2.041	-28.78	-4.768
Net Debt ¹	21.94	28.04	27.34
Reference price ²	0.096000	0.061200	0.005800
Nbr of stocks (in thousands)	31,229	163,181	323,932
Announcement Date	7/12/24	7/12/24	10/3/25

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
BIOSENIC SA	-	-	-	-	1.46M
ELI LILLY AND COMPANY	40.35x	13.85x	30.26x	0.5%	1,224B
JOHNSON & JOHNSON	40.28x	6.76x	19.02x	1.94%	662B
ABBVIE INC.	38.08x	8.51x	17.61x	2.36%	514B
ROCHE HOLDING AG	21.65x	5.25x	13.07x	2.49%	388B
MERCK & CO., INC.	106.67x	5.95x	25.48x	2.33%	361B
NOVARTIS AG	22.86x	5.89x	14.22x	2.75%	302B
ASTRAZENECA PLC	22.82x	4.6x	13.15x	1.92%	271B
AMGEN INC.	29.23x	7.45x	13.34x	2.19%	249B
GILEAD SCIENCES, INC.	-47.64x	7.37x	28.55x	1.99%	205B
Average	30.48x	7.29x	19.41x	2.05%	417.68B
Weighted average by Cap.	36.66x	8.71x	21.55x	1.73%